This HTML5 document contains 57 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n8http://dx.doi.org/10.1160/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q80543288
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en xineru de 2008 article scientifique (publié 2008) наукова стаття, опублікована в січні 2008 im Jahr 2008 veröffentlichter wissenschaftlicher Artikel artikull shkencor i botuar më 01 janar 2008 wetenschappelijk artikel scientific article published on 01 January 2008
p:P577
wds:Q80543288-486A230F-0C71-4171-8E3C-131FDAF07EBA
wdt:P577
2008-01-01T00:00:00Z
p:P2093
wds:Q80543288-6B6039D7-9DCE-4316-A8AD-FA0B1F3855CA wds:Q80543288-35FA2740-E6FF-4ADA-9C60-DF9AB0202EAE wds:Q80543288-2FA1DBB4-4F15-4FD0-AEC3-7C21E8697772 wds:Q80543288-FA5C84BD-70F9-4E01-988A-42A573EC8172 wds:Q80543288-E06FAD2D-0993-45FF-B934-D904C4C2DCD8 wds:Q80543288-E0B07B03-26D8-4605-882C-7C2C7A51D623 wds:Q80543288-D452B40D-3C59-4DFA-AC4E-168963AF9B03 wds:Q80543288-9CFF80B2-084A-4231-BBF2-B1EB043B8294 wds:Q80543288-AC164C57-1A21-485D-902D-2988338D959D
wdt:P2093
Jan van der Meer Thierry Lambert Monika Maas-Enriquez Albert Faradji Elena Santagostino Jørgen Ingerslev Roberto Musso Eduard Gorina KOGENATE Bayer European PMS Study Group
rdfs:label
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting
skos:prefLabel
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting
schema:name
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting
p:P50
wds:Q80543288-55B86F66-98A4-4598-A944-B857E2193BAD
wdt:P50
wd:Q42425494
p:P1476
wds:Q80543288-DBC0F273-5167-49D0-BC22-0180EA8EBC8B
wdt:P1476
Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting
p:P304
wds:Q80543288-8FF79F27-56DD-4E23-9909-812021DE0F9B
wdt:P304
52-58
p:P31
wds:Q80543288-9A0BC07B-5942-48AE-A1AE-F6AD19420534
wdt:P31
wd:Q13442814
p:P698
wds:Q80543288-DEBAA408-401C-4D4D-84BE-A3A7DF6EF3E3
wdtn:P698
n11:18217134
wdt:P698
18217134
p:P1433
wds:Q80543288-FCB52A1A-C6FD-421C-A6F1-F3FA0C54037E
wdt:P1433
wd:Q15724413
p:P433
wds:Q80543288-6CBC705A-7F66-4962-A3CF-63E3D713E655
p:P478
wds:Q80543288-D14E2E45-E525-4EE7-86B0-DA5F06A1D6ED
wdt:P433
1
wdt:P478
99
p:P356
wds:Q80543288-34EE4DB3-E770-4361-8A38-F21F0600FD1C
wdtn:P356
n8:TH07-06-0409
wdt:P356
10.1160/TH07-06-0409